MedPath

Brimrose Technology Corporation

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Yersinia Pestis Lateral Flow Immunoassay for Blood Samples

Conditions
Plague
Yersinia Pestis; Bubo
Yersinia Sepsis
Bubo; Yersinia Pestis
Yersinia Pestis; Pneumonia
Yersinia Pestis Infection
Bubonic; Plague, Skin
Pneumonic Plague
Plague, Bubonic
Plague, Pneumonic
First Posted Date
2020-12-30
Last Posted Date
2022-12-14
Lead Sponsor
Brimrose Technology Corporation
Target Recruit Count
500
Registration Number
NCT04688996
Locations
πŸ‡ΊπŸ‡Έ

US Naval Health Research Center, San Diego, California, United States

πŸ‡²πŸ‡¬

Institut Pasteur de Madagascar, Antananarivo, Analamanga, Madagascar

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.